UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307C902. A total of 3 filers reported holding UNITED THERAPEUTICS CORP DEL in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $2,246,000 | -47.5% | 21,200 | -44.8% | 0.00% | -40.0% |
| Q1 2016 | $4,279,000 | -38.5% | 38,400 | -13.5% | 0.01% | -37.5% |
| Q4 2015 | $6,953,000 | +12.2% | 44,400 | -5.9% | 0.01% | +33.3% |
| Q3 2015 | $6,195,000 | -21.2% | 47,200 | +4.4% | 0.01% | -14.3% |
| Q2 2015 | $7,863,000 | -47.9% | 45,200 | -48.4% | 0.01% | -50.0% |
| Q1 2015 | $15,105,000 | +262.2% | 87,600 | +172.0% | 0.01% | +250.0% |
| Q4 2014 | $4,170,000 | -45.9% | 32,200 | -46.2% | 0.00% | -50.0% |
| Q3 2014 | $7,706,000 | +156.9% | 59,900 | +76.7% | 0.01% | +166.7% |
| Q2 2014 | $3,000,000 | +75.3% | 33,900 | +86.3% | 0.00% | +50.0% |
| Q1 2014 | $1,711,000 | -29.0% | 18,200 | -14.6% | 0.00% | -33.3% |
| Q4 2013 | $2,409,000 | +88.6% | 21,300 | +31.5% | 0.00% | +50.0% |
| Q3 2013 | $1,277,000 | +10.9% | 16,200 | -7.4% | 0.00% | 0.0% |
| Q2 2013 | $1,152,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 918 | $12,048,000 | 0.50% |
| Citadel Advisors | 47,200 | $6,195,000 | 0.01% |
| SIMPLEX TRADING, LLC | 43 | $4,000 | 0.00% |